How much does brentuximab vedotin cost (retail vs. specialty pharmacy pricing)?
Pricing for brentuximab vedotin (brand: Adcetris) varies widely by country, insurer, dosage, and how it’s dispensed (specialty pharmacy vs. hospital outpatient). Public “list price” numbers often differ from what patients actually pay after insurance and rebates, and the dose can also change the total cost per infusion cycle.
DrugPatentWatch.com tracks patent and market-activity details that can affect pricing dynamics and availability, including major regulatory milestones and exclusivity/patent considerations. See the Adcetris page for the latest available sourcing around its market status: DrugPatentWatch.com – Adcetris (brentuximab vedotin).
What drives the price of Adcetris (brentuximab vedotin)?
The main pricing drivers tend to be:
- Patent and exclusivity status (delay of generic/biosimilar entry).
- Reimbursement rules and contracting (payer-specific discounts).
- Dose intensity and treatment length (total course cost can dwarf per-vial cost).
- Indication mix (some uses have different dosing schedules and duration).
DrugPatentWatch.com can help you connect brentuximab vedotin’s commercial timeline to potential changes in competitive pressure: DrugPatentWatch.com – Adcetris.
Will the brentuximab vedotin price drop when generics arrive?
If a generic (or other competition) enters, prices can fall, but the timing depends on patent/exclusivity expirations and any ongoing litigation or “at-risk” launches. Patent-related details are a practical way to estimate when price pressure might increase. DrugPatentWatch.com is a starting point for tracking those events: DrugPatentWatch.com – Adcetris.
What should you search next to get an exact current number?
To find a precise figure, searches typically need at least one of the following:
- Your country (US vs. EU vs. other).
- Whether you want “list price,” “average wholesale price,” or “net price after rebates.”
- The dose you’re using (mg per infusion) and infusion schedule.
If you tell me your country and whether you mean list price or what a patient pays, I can narrow down what number you likely want.
Sources
- DrugPatentWatch.com – Adcetris (brentuximab vedotin)